About
OutSee develops an AI-driven genomics platform called Nomaly that predicts disease and phenotype directly from individual genomes by uncovering underlying molecular and cellular biological mechanisms rather than relying on known genetic associations.
Explore OutSee's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.